$2.39 Billion is the total value of Artal Group S.A.'s 139 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 64.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | Sell | BEIGENE LTDsponsored adr | $125,419,000 | -31.4% | 665,000 | -1.5% | 5.25% | +5.8% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $110,997,000 | -46.0% | 1,350,000 | -3.6% | 4.65% | -16.6% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $37,880,000 | -45.3% | 4,000,000 | -33.3% | 1.59% | -15.6% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $33,270,000 | -32.1% | 500,000 | -28.6% | 1.39% | +4.8% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $24,825,000 | -41.6% | 750,000 | -25.0% | 1.04% | -10.0% |
| RLAY | Sell | RELAY THERAPEUTICS INC | $20,951,000 | -9.0% | 700,000 | -6.7% | 0.88% | +40.3% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $18,946,000 | -55.7% | 800,100 | -36.0% | 0.79% | -31.6% |
| AGEN | Sell | AGENUS INC | $13,530,000 | -35.4% | 5,500,000 | -15.4% | 0.57% | -0.4% |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $12,872,000 | -49.2% | 400,000 | -26.5% | 0.54% | -21.5% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $9,290,000 | -60.7% | 1,000,000 | -33.3% | 0.39% | -39.3% |
| Sell | CARIBOU BIOSCIENCES INC | $967,000 | -84.2% | 105,347 | -74.0% | 0.04% | -75.9% | |
| SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| DLO | Exit | DLOCAL LTD | $0 | – | -20,000 | -100.0% | -0.02% | – |
| Exit | RIVIAN AUTOMOTIVE INC | $0 | – | -7,000 | -100.0% | -0.02% | – | |
| MBII | Exit | MARRONE BIO INNOVATIONS INC | $0 | – | -1,048,679 | -100.0% | -0.02% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -321,100 | -100.0% | -0.02% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -100,000 | -100.0% | -0.03% | – |
| AMYT | Exit | AMRYT PHARMA PLCsponsored ads | $0 | – | -150,480 | -100.0% | -0.04% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -180,500 | -100.0% | -0.08% | – |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -0.11% | – |
| IQ | Exit | IQIYI INCsponsored ads | $0 | – | -1,000,000 | -100.0% | -0.12% | – |
| GDS | Exit | GDS HLDGS LTDsponsored ads | $0 | – | -100,000 | -100.0% | -0.13% | – |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -1,045,000 | -100.0% | -0.14% | – |
| EVLO | Exit | EVELO BIOSCIENCES INC | $0 | – | -1,000,000 | -100.0% | -0.16% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -250,000 | -100.0% | -0.32% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -600,000 | -100.0% | -0.38% | – |
| NG | Exit | NOVAGOLD RES INC | $0 | – | -2,600,000 | -100.0% | -0.48% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.60% | – |
| C | Exit | CITIGROUP INCcall | $0 | – | -1,000,000 | -100.0% | -1.64% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -1,000,000 | -100.0% | -1.69% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -1,000,000 | -100.0% | -3.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.